News
TMDX
75.63
+9.47%
6.54
Buying The Dip: How TransMedics Is Set To Soar In A Potential $23 Billion Market
Seeking Alpha · 7h ago
Piper Sandler Sticks to Its Buy Rating for TransMedics Group (TMDX)
TipRanks · 12h ago
Weekly Report: what happened at TMDX last week (1230-0103)?
Weekly Report · 13h ago
Breaking Into Healthcare: Why TransMedics Is My Bold First Move
Seeking Alpha · 1d ago
5 Cheap Growth Stocks For 2025
Seeking Alpha · 1d ago
Here's How Much You Would Have Made Owning TransMedics Gr Stock In The Last 5 Years
Benzinga · 5d ago
TCMD Stock Rises 20% in Three Months: Should You Buy, Hold or Sell?
Barchart · 12/31/2024 08:58
Weekly Report: what happened at TMDX last week (1223-1227)?
Weekly Report · 12/30/2024 10:15
ABAT, KULR and GME among trending stocks in the slow holiday-shortened week
Seeking Alpha · 12/28/2024 18:33
Weekly Report: what happened at TMDX last week (1216-1220)?
Weekly Report · 12/23/2024 10:19
Looking Into TransMedics Gr's Recent Short Interest
Benzinga · 12/20/2024 14:00
$100 Invested In TransMedics Gr 5 Years Ago Would Be Worth This Much Today
Benzinga · 12/19/2024 15:00
BUZZ-TransMedics Group down after J.P.Morgan downgrades stock to 'neutral'
Reuters · 12/17/2024 12:21
TransMedics Group Price Target Cut to $75.00/Share From $116.00 by JP Morgan
Dow Jones · 12/17/2024 12:10
TransMedics Group Cut to Neutral From Overweight by JP Morgan
Dow Jones · 12/17/2024 12:10
JP Morgan Downgrades TransMedics Gr to Neutral, Lowers Price Target to $75
Benzinga · 12/17/2024 11:59
TransMedics downgraded to Neutral from Overweight at JPMorgan
TipRanks · 12/17/2024 10:20
U.S. RESEARCH ROUNDUP-Domino's Pizza, Honeywell, Walmart
Reuters · 12/17/2024 07:19
TRANSMEDICS GROUP INC <TMDX.O>: JP MORGAN CUTS TO NEUTRAL FROM OVERWEIGHT; CUTS TARGET PRICE TO $75 FROM $116
Reuters · 12/17/2024 05:28
Weekly Report: what happened at TMDX last week (1209-1213)?
Weekly Report · 12/16/2024 10:20
More
Webull provides a variety of real-time TMDX stock news. You can receive the latest news about Transmedics Group through multiple platforms. This information may help you make smarter investment decisions.
About TMDX
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside of the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ retrieval, OCS organ management and logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation, ground transportation and other coordination activity. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.